Remuneration Report 3. 2025 Global Remuneration Framework 3.1 Alignment of Executive reward to CSL’s purpose and strategy To deliver on its promise to patients, CSL relies on its people and maintaining a strong supply of global talent. CSL’s approach to rewards is aligned to its purpose and business strategy (summarised below) and enables CSL to attract, engage and retain talent, provide flexibility to address talent challenges in various markets, and allows CSL to compete with other large global pharmaceutical companies. OUR FOCUS OUR AMBITIONS CSL’s strategy VALUES CSL Values are at the core of how employees interact with each other, make decisions and solve problems. Patient Focus – Make people and patients your passion Integrity – Walk your talk Innovation – Reach for the unreachable Superior Performance – Make yourself proud Collaboration – Adventure together THERAPEUTIC AREAS Immunoglobulins Transplant and Immunology Haematology Cardiovascular and Renal Vaccines Patients Who need durable, effective treatment for, and protection from serious disease Drive growth through Portfolio Development & Commercialization Cross-functional portfolio leadership in how we source, discover, develop and drive demand for our life-changing medicines Diseases Where we have a fundamental advantage in understanding the disease and science Create value through operational excellence Operational excellence across our network, undisputed end-to-end plasma leadership and accelerating enterprise initiatives to unlock value Medicines With a high degree of specialist expertise of manufacturing differentiation Enable our people and partners to deliver the company’s future Agile & empowered employees living our values, hand-in-hand with trusted partners, supported by business-focused enabling functions & transformative digital capabilities Our Strategic Ambition To deliver enduring patient impact in areas of high unmet medical need FOCUS ON DELIVERING ENDURING PATIENT IMPACT VALUES THERAPEUTIC AREAS TO DELIVER THIS WE WILL: 68 Directors’ Report
RkJQdWJsaXNoZXIy MjE2NDg3